Hantavirus Pulmonary Syndrome (HPS) is a rare yet potentially fatal respiratory disease caused by infection with hantaviruses. First recognized in the United States in 1993, this illness has since raised significant public health concerns due to its rapid progression and high mortality rate. Though relatively uncommon, understanding the disease, its transmission, symptoms, and preventive strategies is crucial—especially for people living in or visiting rural or wilderness areas.

This blog explores all key aspects of HPS, including its causes, symptoms, diagnosis, treatment options, and prevention.

What is Hantavirus Pulmonary Syndrome?

Hantavirus Pulmonary Syndrome is a severe respiratory illness resulting from infection with New World hantaviruses, which are primarily carried by rodents. The disease progresses in two stages—initial flu-like symptoms followed by sudden and severe respiratory distress.

The Sin Nombre virus, carried by the deer mouse, is the most common cause of HPS in North America. The disease has a high fatality rate—around 38%, according to the U.S. Centers for Disease Control and Prevention (CDC).

Causes and Transmission

Hantaviruses are primarily spread to humans through exposure to infected rodent urine, droppings, or saliva. The most common ways the virus is transmitted include:

  • Inhalation of Aerosolized Virus: When rodent waste dries, it can become airborne, allowing people to breathe in tiny virus particles.

  • Direct Contact: Touching rodent droppings or nesting materials and then touching the mouth or nose.

  • Rodent Bites: Though rare, a bite from an infected rodent can transmit the virus.

Common Rodent Carriers

Different species of rodents are responsible for spreading different types of hantavirus:

Rodent SpeciesVirus TypeRegion
Deer mouseSin Nombre virusNorth America
Cotton ratBlack Creek Canal virusSoutheastern US
White-footed mouseNew York virusNortheastern US
Rice ratBayou virusSoutheastern US

Human-to-human transmission is extremely rare and has only been documented with Andes virus in South America.

Who is at Risk?

People at higher risk for HPS include:

  • Farmers, construction workers, and pest control workers.

  • People living in rural areas or near forests.

  • Campers and hikers.

  • Anyone cleaning out barns, sheds, or cabins infested by rodents.

While HPS can affect anyone regardless of age or health status, most reported cases occur in healthy adults, likely due to higher outdoor exposure.

Symptoms of Hantavirus Pulmonary Syndrome

HPS symptoms typically appear 1 to 8 weeks after exposure to the virus. The illness progresses through two main stages:

1. Prodromal Phase (Early Symptoms)

This phase lasts for 3–7 days and includes nonspecific, flu-like symptoms such as:

Because the early symptoms mimic those of many viral infections, they are often overlooked or misdiagnosed.

2. Cardiopulmonary Phase (Advanced Symptoms)

Within a few days, the illness escalates rapidly, often requiring emergency medical attention:

Without prompt treatment, this phase can lead to shock, organ failure, and death.

Diagnosis

Diagnosing HPS can be challenging due to the nonspecific nature of early symptoms. Physicians often consider the possibility of HPS if the patient:

  • Has a history of rodent exposure.

  • Lives in or has traveled to endemic areas.

  • Shows signs of respiratory distress without a clear cause.

Diagnostic Tests

  1. Serologic Tests: Detect antibodies (IgM and IgG) against hantavirus in the blood.

  2. PCR (Polymerase Chain Reaction): Detects hantavirus RNA in blood or tissue samples.

  3. Chest X-ray: May show fluid in the lungs, which supports clinical suspicion.

Early diagnosis is critical for improving outcomes.

Treatment

There is no specific antiviral treatment or cure for HPS. Medical care focuses on supportive therapy, particularly during the critical cardiopulmonary phase.

Supportive Care Includes:

  • Oxygen therapy: To help with breathing difficulties.

  • Mechanical ventilation: In severe cases, when the patient is unable to breathe effectively on their own.

  • Fluid management: To prevent fluid overload while maintaining blood pressure.

  • Intensive Care Monitoring: Necessary due to the potential for rapid deterioration.

Experimental Treatments

Some antiviral agents like ribavirin have been tested in laboratory settings, but they are not yet proven effective for HPS and are not routinely used.

Prognosis and Survival

The mortality rate of HPS is approximately 38%, primarily due to respiratory failure and shock. However, early recognition and aggressive supportive care significantly improve survival chances.

Patients who survive the acute phase usually recover completely, though full recovery may take weeks or months.

Prevention

Preventing HPS involves avoiding contact with infected rodents and their droppings. Key preventive measures include:

1. Rodent Control

  • Seal holes and gaps in homes, cabins, and outbuildings.

  • Store food in rodent-proof containers.

  • Eliminate nesting sites such as woodpiles and clutter.

  • Use snap traps or rodent bait stations where appropriate.

2. Safe Cleaning Practices

  • Ventilate closed spaces (sheds, attics) for 30+ minutes before cleaning.

  • Wear gloves and masks when cleaning rodent-infested areas.

  • Use disinfectant (bleach solution) before sweeping or mopping.

  • Avoid vacuuming or dry sweeping rodent droppings to prevent aerosolization.

3. Outdoor Safety

  • Use tents with floors when camping.

  • Keep food sealed and dispose of trash properly.

  • Avoid sleeping near rodent nests or burrows.

Global Perspective

Hantavirus infections are not confined to the Americas. In Asia and Europe, Old World hantaviruses such as Hantaan virus, Dobrava virus, and Puumala virus cause a related disease called Hemorrhagic Fever with Renal Syndrome (HFRS), which primarily affects the kidneys.

Unlike HPS, HFRS is more common in China, Russia, and parts of Europe.

Key Differences: HPS vs. HFRS

FeatureHantavirus Pulmonary Syndrome (HPS)Hemorrhagic Fever with Renal Syndrome (HFRS)
RegionAmericasAsia and Europe
Organs AffectedLungs (respiratory system)Kidneys (renal system)
Main SymptomsRespiratory distress, pulmonary edemaFever, kidney dysfunction, hemorrhage
Fatality Rate~38%1–15% (varies by virus strain)

Outbreaks and Case Reports

Since 1993, over 800 cases of HPS have been confirmed in the U.S., primarily in rural areas of western states like New Mexico, Colorado, and Arizona. Notable outbreaks have occurred in:

  • Yosemite National Park (2012): Multiple cases linked to tent cabins infested with deer mice.

  • Argentina and Chile: Cases of Andes virus, some with human-to-human transmission.

These incidents underscore the importance of awareness and rodent control, especially in high-risk environments.

Hantavirus and Public Health

While HPS remains rare, it is classified as a reportable disease in many countries, including the United States. Public health authorities work to monitor cases, identify outbreaks, and educate the public.

Role of Public Health Agencies

  • Surveillance and outbreak investigation

  • Public education on rodent control

  • Collaborations with wildlife and environmental agencies

  • Research on virus ecology and vaccine development

Research and Future Directions

Current research on hantavirus focuses on:

  • Vaccine development: Various vaccines are in preclinical stages, especially in Asia where HFRS is more common.

  • Rodent population studies: Understanding how climate and environment affect rodent behavior and virus transmission.

  • Antiviral therapy: Identifying potential drug candidates to treat or prevent infection.

Hantavirus Pulmonary Syndrome is a deadly but preventable disease. Although rare, the rapid onset and severity of symptoms make it a critical public health concern, particularly in rodent-prone environments. By staying informed and practicing simple preventive measures—such as rodent-proofing your surroundings and using safe cleaning techniques—you can significantly reduce your risk.

Awareness, early diagnosis, and prompt medical attention remain the cornerstones in the fight against this serious disease. As researchers work toward better treatments and possible vaccines, public education remains our first line of defense.

References:

  1. Centers for Disease Control and Prevention (CDC) – Hantavirus

  2. World Health Organization (WHO)

  3. U.S. National Library of Medicine

  4. Mayo Clinic – Hantavirus Pulmonary Syndrome

 

 

If you’re looking for expert diagnosis and personalized care, Sparsh Diagnostic Centre is here to help.
Contact: 📞 9830117733 / 8335049501
Open: Monday to Saturday: 7 AM – 9 PM | Sunday: 7 AM – 3 PM

🌐 Learn more

#BhaloTheko

 

Disclaimer:

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

 

Sparsh Doctor List

Loading

One Reply to “Hantavirus Pulmonary Syndrome”

  1. How long would this last if not treated, I have MG and was exposed to large amount rat feces in December of 2023, my symptoms are giving the medical staff a lot of unanswered questions. Could my exposeure have something to do with it……….I’m really struggling and have had 2 treatments of IVIG (April and May) so far, with symptoms getting worse in June…….

    Symptoms: chest tightness, SOB, large amounts of mucus in ………

    Just trying to see if I can get answers.

    Thank you.

Leave a Reply

Your email address will not be published. Required fields are marked *

This field is required.

This field is required.